Citigroup’s Artelo Biosciences ARTL Stock Holding History

Citigroup’s Portfolio ARTL Stock Details ARTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.3K	Buy	+3,076	New	+$14.5K	﹤0.01%	4780
2025 Q4	–	Sell	-159	Closed	-$2.19K	–	6055
2025 Q3	$2.19K	Buy	159 +156	+5,200%	+$4.78K	﹤0.01%	5461
2025 Q2	$119	Buy	+3	New	+$55	﹤0.01%	5506
2024 Q3	–	Sell	-3	Closed	-$64	–	5671
2024 Q2	$64	Buy	+3	New	+$75	﹤0.01%	5468

Other funds holding ARTL

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

KCM

Kathmere Capital Management Wayne, Pennsylvania $1.62B AUM 17.7% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup's ARTL Position: Q1 2026 in Review

Citigroup opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 3,076 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #4780 among its holdings. This is a return to the name: Citigroup previously reported a position in ARTL as recently as Q3 2025.

Citigroup first reported a position in ARTL in Q2 2024 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

Citigroup held 3,076 shares of Artelo Biosciences worth $23.3K as of Q1 2026.
Artelo Biosciences was a new Citigroup position in Q1 2026.
Artelo Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4780 holding.
Citigroup first reported a position in Artelo Biosciences in Q2 2024 and has held it in 4 quarters since.
11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.